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Cervical lymphadenitis as a result of nontuberculous mycobacteria, otherwise known as
scrofula, is a disease occurring almost exclusively in immunocompetent young children.
The most frequent mycobacterial species responsible is Mycobacterium avium, but a large
number of other species may also be involved. The epidemiology of such disease is revised
here, and the impact of different species as causative agents of adenitis is also discussed.
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Scrofula is a mycobacterial disease of the lymph nodes of the
head and neck well known during ancient times; in the Mid-
dle Ages, it was also called the ‘‘king’s evil,’’ as it was believed
the disease could be healed by the touch of royalty. Both
tuberculous and nontuberculous mycobacteria (NTM) can be
responsible for cervical lymphadenitis.
The cases of scrofula, which were very common in the
past, are, at least in the great majority, imputable to Mycobac-
terium tuberculosis and Mycobacterium bovis; in the xx century
this kind of disease has steadily decreased and is now very
rare in developed countries, but, starting with the 1950s, an
increasing number of cases as a result of NTMs have been re-
ported [1].
Scrofula is typically a disease of childhood, but rare cases
in adults have also been documented. The focus of this review
is on the epidemiology of cervical lymphadenitis of otherwise
healthy children, with the exclusion therefore of cases affect-
ing immunocompromised patients.Clinical notes
The disease typically affects immunocompetent children,
most prevalent in those between the ages of 1 and 5 years
old. It is hypothesized that NTMs present in the environment
are ingested and enter the body through lesions in the oral
mucosa (e.g. in concomitance with dental eruption), or by
way of the lymphatic vessels that drain the mouth and phar-
ynx. The lymph nodes most commonly affected include the
jugulodigastric, submandibular, parotid/pre-auricular, sub-
mental and posterior triangle. In most of the cases, the pa-
tient is asymptomatic; less frequent symptoms can include
a slight fever and malaise. The first manifestation is a non-
tender, indolent, mostly unilateral swelling (1–6 cm) which
subsequently enlarges and, in consequence of the necrosis
of the central part of the granulomatous lesions, liquefies
becoming fluctuant. The skin becomes often violaceous as a
consequence of the inflammatory reaction, and frequently
the necrotic collection fistulizes.
In a limited number of cases, spontaneous healing occurs
by fibrosis and calcification; regression is quite rare.
The initial stages of the disease are frequently interpreted
as an incidental upper respiratory tract infection and antibi-
otics are prescribed which, however, prove to be ineffective.
Differential diagnosis with tuberculous or pyogenic adenitis
is needed, and the isolation of the agent in a culture is of par-
amount importance. For this purpose, the use of a liquid med-
ia is advisable to reduce the burden of cases with positive
acid-fast microscopy which fails to grow if cultured on solid
media only.
The skin test based on intradermal inoculation of sensi-
tins, tuberculin analogs specific from the most common
NTMs, has been used for many years to diagnose, in absence
of a culture, NTM lymphadenitis; the diagnostic accuracy of
such tests is at least questionable because of the high level
of cross-reactions between the different antigens and with
the tuberculin skin test itself. The discontinuation of com-mercialization of sensitins, despite the regret of some pedia-
tricians, confirms their limited value.
The most resolutive intervention is nowadays considered
the complete excision of the affected lymph nodes before
the suppuration occurrence; the healing is obtained in a large
proportion of cases, but recurrences are not exceptional.
Other less usual possibilities include no intervention, antimi-
crobial therapy alone, fine needle aspiration and incision fol-
lowed by drainage or curettage.Epidemiology
Differently from NTMs isolated from pulmonary specimens –
which only in a limited number of cases are clinically signif-
icant – the mycobacteria isolated from lymph nodes can
never be considered contaminants or colonizers. The number
of NTM species responsible for cervical lymphadenopathy is
very high, and so far some of them have only been isolated
from lymph nodal biopsies.
Mycobacterium scrofulaceum
M. scrofulaceum is one of the oldest of the NTM species; it was
described in 1956 by Prissick and Masson in a report concern-
ing ten cases of a new variant of scrofula presenting with a
nontuberculous etiology [2]. Major emphasis is placed in this
paper on the slow growth and the yellow pigmentation of the
newly detected mycobacterium. The vagueness of such fea-
tures, compatible with many mycobacterial species, were,
along with the name ‘‘scrofulaceum’’, destined to influence
the identification of mycobacteria isolated from adenitis over
a long period of time.
Beginning in the 1970s, Wolinsky [3] reported an ‘‘abrupt
change in thepredominant etiologic agent fromM.scrofulaceum
to Mycobacterium avium complex’’ (MAC). Both the prevalent
involvement of MAC and the paucity of cases due to
M. scrofulaceum remain unchanged nowadays.
MAC
The first case of cervical lymphadenitis due to M. avium was
reported in 1959 [4]; in subsequent years, when the taxonomic
status of MAC was still far from being defined and related
organisms were referred to as ‘‘Battey group’’, the first case
series were published [5,6]. Starting in the 1980s, Mycobacte-
rium intracellulare was also beginning to be reported among
the agents of lymphadenitis. It remains, however, undistin-
guished from M. avium of which it is considered a variant
[7]. The introduction of serotyping made for the first time pos-
sible a reliable distinction between M. avium and M. intracellu-
lare, but, at the same time, produced the ambiguity of the
association of such species with M. scrofulaceum, in the M. avi-
um-intracellulare-scrofulaceum (MAIS) group [8]. With the com-
mercialization of the nucleic acid probes, the definitive
distinction of M. avium and M. intracellulare became within
the reach of diagnostic laboratories.
Recently, a large-scale study [9] did not detect any case due
to M. intracellulare in a group of children with adenitis. The
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M. avium investigated belonged to the subspecies hominissuis,
with M. avium subsp. avium being totally absent.
In recent years, MAC has been enriched by several new
species; of them, only Mycobacterium colombiense has been re-
ported responsible for lymphadenitis [10,11].
Mycobacterium simiae complex
M. simiae, grown for the first time from a monkey, is a multi-
drug-resistant species frequently isolated in several geo-
graphic areas, in particular South-Western USA, Cuba and
Israel. It is therefore not surprising that the involvement of
this species in cases of adenitis has been reported right in
these countries [12,13].
A number of species, genetically related to M. simiae, have
been described in recent years; many of them have been re-
ported responsible for scrofula. Mycobacterium genavense, a
species well known for its inability to grow on conventional
solid media and for the high number of disseminated infec-
tions in severely immunocompromised AIDS patient, is one
of them [14]. Mycobacterium interjectum was first described fol-
lowing the isolation from a lymph nodal infection in a child
[15], and many other isolates have been reported thereafter
[16–18]. Two of the strains on which is based the description
of Mycobacterium triplex [19] had been grown from lymph
nodes. Particularly high is the number of cases reported so
far related to Mycobacterium lentiflavum [20–24]. The papers
describing the species Mycobacterium heidelbergense [25], Myco-
bacterium palustre [26], Mycobacterium parmense [27], Mycobacte-
rium florentinum [28] and Mycobacterium europaeum [29] all
include one isolation from chronic pediatric
lymphadenopathy.
Mycobacterium haemophilum
Despite M. haemophilum is a fastidious organism which is of-
ten missed in culture because of the requirement of particular
growth supplements and lower incubation temperatures, the
number of pediatric lymphadenitis due to this organism is
quite high. A very recent review [30] reports a particularly
high frequency in Israel and The Netherlands where the M.
haemophilum is the second most frequent organism responsi-
ble for such disease after M. avium. In a Dutch study [31] infec-
tions due to M. haemophilum, different from those due to M.
avium, are associated with the involvement of multiple lymph
nodes and extranodal areas.
Other slowly growing species
Mycobacteriummalmoense is one of the species more frequently
isolated from cervical lymphadenitis [32]; in countries where
this organism is endemic, mainly the United Kingdom and
Sweden, it ranks second after M. avium. Similar is the case of
Mycobacterium kansasii, which in a recent paper [33] is reported
to account for 5% of pediatric cervico-facial adenitis; more rare
are the cases due to Mycobacterium celatum [34,35].
Among the species rarely isolated in clinical laboratories,
at least one isolation from cervical lymphadenitis is reported
for each of the following: Mycobacterium heidelbergense [25],Mycobacterium mantenii [36], Mycobacterium palustre [26], Myco-
bacterium tusciae [37] and Mycobacterium asiaticum [38]. In most
cases, such strains were included among the ones character-
ized for the description of the new species. Mycobacterium
bohemicum, an uncommon mycobacterium indeed, has been
reported responsible for a relatively high number of cases of
scrofula [39].
Mycobacterium gordonae and the members of the Mycobacte-
rium terrae complex are only exceptionally responsible for dis-
ease in humans. Such characteristic is apparently confirmed
for adenitis since for the first species, there is only one report
present in literature [40], and only two cases – one due to
Mycobacterium arupense [41] and one to Mycobacterium terrae
[42] – are reported so far for the M. terrae complex.
Rapidly growing species
The numerous cases reported above – all related to slowly
growing species – clearly contrast with the paucity of cases
imputable to rapid growers. Their isolation from cervico-fa-
cial lymphadenitis is extremely rare and limited to the three
most common species: Mycobacterium fortuitum, Mycobacte-
rium chelonae [43] and Mycobacterium abscessus [44].Discussion
The epidemiologic picture emerging from this review is not
exempt from the following biases:
• The high proportion of cases of M. scrofulaceum reported
until the 1980s is at least in part questionable: a number
of species, among which M. lentiflavum, M. tusciae, M.
bohemicum and many others, fit the rough characteristics
taken into account initially to characterize M. scrofulaceum.
Furthermore, the term ‘‘scrofulaceum’’ itself may well
have played a role in the direct assignment of such species
of many of the scotochromogenic slow growers isolated
from cases of scrofula.
• The use of biochemical tests, widespread until the end of
the last century, leads to wrongly assigning all the less fre-
quently encountered NTMs to just one of the species (usu-
ally no more than about 30) present in the identification
tables available in microbiological manuals.
• Even the use of more recent and more accurate methods
like nucleic-acid probes is not exempt from the incorrect
identifications due to cross-reactivity of some of the
probes (Table 1).
• The lack of expertise may also lead to incorrect identifica-
tion even by the users of genetic sequencing once dat-
abases that are not exhaustive or are not controlled are
used [45].
It seems, therefore, not rash to assert that the role of M.
scrofulaceum is - in literature related to pediatric cervical
lymphadenitis – highly overestimated while, in contrast, is
underestimated the involvement of many of the species de-
scribed in the last 20 years.
It is now generally accepted that NTM species differ in
their ability to cause lung disease in humans [46,47]. While
Table 1 – Species whose prevalence in cervical lymphadenitis is underestimated because of cross-reactions of commercial
nucleic-acid probes [48] (only the species isolated at least once from cervical lymphadenitis are included).
Species Misidentifications due to cross-reactions of
AccuProbea INNO LiPA mycobacteriab Genotype mycobacterium CM
M. colombiense M. intracellulare
M. heidelbergense MAIS
M. mantenii MAIS M. intracellulare
M. nebraskense MAC or M. intracellulare M. intracellulare
M. palustre MAC
M. parascrofulaceum M. scrofulaceum M. scrofulaceum
M. sherrisii M. simiae M. simiae
a MAC, M. avium complex.
b MAIS, M. avium-intracellulare-scrofulaceum group.
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contaminants from causative agents of disease does exist, the
strains isolated from lymphadenitis (from excised lymph
nodes, fine needle aspirates, and drainage material) are ipso
facto clinically significant, thus making easy the speculation
on different potentials of single species in infecting lymph
nodes.
Although it seems certain that lymph nodal NTM infection
originates from the environment, no direct connection exists
between the prevalence of different species in the environ-
ment and their involvement in cases of adenitis. The case
of MAC is striking; the two major species – M. avium and M.
intracellulare – are both very common in the environment,
but while the adenitis due to M. avium has by far the highest
incidence, the cases due to M. intracellulare are, if any, extre-
mely rare. Mycobacterium xenopi, one of the most prevalent
species in many countries of Europe where it is often respon-
sible for severe pulmonary diseases, has never been isolated
from lymph nodes. Apart from M. avium, only one species
among the most frequently isolated is involved in a balanced
proportion in pulmonary and lymph nodal diseases: M.
malmoense.
It is surprising, in contrast, that species for which little
awareness still exists in clinical laboratories are frequently
isolated from scrofula: M. lentiflavum, M. bohemicum and M.
interjectum are the most striking examples.
The involvement of rapidly growing mycobacteria in pedi-
atric lymphadenitis is restricted to a very limited number of
cases.
It seems likely, therefore, that although a ranking in path-
ogenic potential of different NTMs exists, this is not absolute,
but rather organ-specific. Of the top pathogens for the lung,
only M. malmoense is ranked for lymph nodes too. Other major
responsible of lymphadenitis include, in adjunct to M. avium
and M. haemophilum, most of the species of the M. simiae com-
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